JP2023538619A5 - - Google Patents
Info
- Publication number
- JP2023538619A5 JP2023538619A5 JP2023512228A JP2023512228A JP2023538619A5 JP 2023538619 A5 JP2023538619 A5 JP 2023538619A5 JP 2023512228 A JP2023512228 A JP 2023512228A JP 2023512228 A JP2023512228 A JP 2023512228A JP 2023538619 A5 JP2023538619 A5 JP 2023538619A5
- Authority
- JP
- Japan
- Prior art keywords
- benzo
- imidazole
- phenyl
- methylsulfonyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063067587P | 2020-08-19 | 2020-08-19 | |
| US63/067,587 | 2020-08-19 | ||
| PCT/US2021/046421 WO2022040260A1 (en) | 2020-08-19 | 2021-08-18 | 1h-benzo[d]imidazole derivatives as tlr9 inhibitors for the treatment of fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538619A JP2023538619A (ja) | 2023-09-08 |
| JP2023538619A5 true JP2023538619A5 (enExample) | 2024-08-26 |
Family
ID=77693625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512228A Pending JP2023538619A (ja) | 2020-08-19 | 2021-08-18 | 線維症の処置のためのｔｌｒ９阻害剤としての１ｈ－ベンゾ［ｄ］イミダゾール誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12492188B2 (enExample) |
| EP (1) | EP4200292B1 (enExample) |
| JP (1) | JP2023538619A (enExample) |
| KR (1) | KR20230053645A (enExample) |
| CN (1) | CN116075510A (enExample) |
| AR (1) | AR123286A1 (enExample) |
| AU (1) | AU2021329323A1 (enExample) |
| BR (1) | BR112023002645A2 (enExample) |
| CA (1) | CA3189873A1 (enExample) |
| CL (1) | CL2023000440A1 (enExample) |
| CO (1) | CO2023001668A2 (enExample) |
| ES (1) | ES2999539T3 (enExample) |
| IL (1) | IL300702A (enExample) |
| MX (1) | MX2023001884A (enExample) |
| PE (1) | PE20230843A1 (enExample) |
| TW (1) | TW202227409A (enExample) |
| WO (1) | WO2022040260A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11807622B2 (en) | 2019-01-30 | 2023-11-07 | Insilico Medicine Ip Limited | TLR 9 inhibitors |
| JP2025508741A (ja) * | 2022-02-18 | 2025-04-10 | ブリストル－マイヤーズ スクイブ カンパニー | Ｔｌｒ９の阻害剤として有用な置換された二環ヘテロアリール化合物 |
| KR20240148414A (ko) * | 2022-02-18 | 2024-10-11 | 브리스톨-마이어스 스큅 컴퍼니 | Tlr9의 억제제로서 유용한 치환된 이미다조피리디닐 화합물 |
| CN117466863B (zh) * | 2022-07-20 | 2026-03-24 | 盛睿泽华医药科技（苏州）有限公司 | 含芳香族取代基的苯并咪唑化合物及其制备方法和用途 |
| WO2024102886A1 (en) * | 2022-11-10 | 2024-05-16 | Bristol-Myers Squibb Company | Substituted benzimidazole compounds useful as inhibitors of tlr9 |
| CN120152957A (zh) * | 2022-11-10 | 2025-06-13 | 百时美施贵宝公司 | 用作tlr9抑制剂的经取代的喹诺酮 |
| WO2024163380A1 (en) * | 2023-01-31 | 2024-08-08 | Bristol-Myers Squibb Company | Substituted benzimidazole compounds useful as inhibitors of tlr9 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008504233A (ja) * | 2004-04-23 | 2008-02-14 | パラテック ファーマシューティカルズ インコーポレイテッド | 転写因子調節化合物およびその使用法 |
| WO2007115306A2 (en) | 2006-04-04 | 2007-10-11 | Myriad Genetics, Inc. | Compounds for diseases and disorders |
| US20060235037A1 (en) | 2005-04-15 | 2006-10-19 | Purandare Ashok V | Heterocyclic inhibitors of protein arginine methyl transferases |
| GB0602178D0 (en) | 2006-02-03 | 2006-03-15 | Merck Sharp & Dohme | Therapeutic treatment |
| CA2738929A1 (en) | 2008-10-17 | 2010-04-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| US20130158049A1 (en) | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 7-azaindole inhibitors of crac |
| US20130158066A1 (en) | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 4-azaindole inhibitors of crac |
| EA201400990A1 (ru) | 2012-04-06 | 2015-01-30 | Пфайзер Инк. | Ингибиторы диацилглицеринацилтрансферазы 2 |
| WO2013156431A1 (en) | 2012-04-17 | 2013-10-24 | Syngenta Participations Ag | Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives |
| JP6168055B2 (ja) | 2012-06-18 | 2017-07-26 | 住友化学株式会社 | 縮合複素環化合物 |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| EP3080124A1 (en) | 2013-12-13 | 2016-10-19 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors |
| AR107032A1 (es) | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores bicíclicos de pad4 |
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| MX391344B (es) | 2016-07-30 | 2025-03-21 | Bristol Myers Squibb Co | Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9). |
| KR102519535B1 (ko) | 2016-09-09 | 2023-04-06 | 브리스톨-마이어스 스큅 컴퍼니 | 피리딜 치환된 인돌 화합물 |
| US11370794B2 (en) * | 2016-11-11 | 2022-06-28 | Dynavax Technologies Corporation | Toll-like receptor antagonist compounds and methods of use |
| CN110891949B (zh) | 2017-07-05 | 2023-05-23 | 先正达参股股份有限公司 | 具有含硫取代基的杀有害生物活性杂环衍生物 |
| ES2921020T3 (es) | 2017-08-04 | 2022-08-16 | Bristol Myers Squibb Co | Compuestos de indol sustituidos con [1,2,4]triazolo[4,3-a]piridinilo |
| CN110997656B (zh) | 2017-08-04 | 2023-04-14 | 百时美施贵宝公司 | 用作tlr7/8/9抑制剂的取代的吲哚化合物 |
| CN111448190B (zh) | 2017-11-14 | 2023-09-26 | 百时美施贵宝公司 | 取代的吲哚化合物 |
| BR112020011668A2 (pt) | 2017-12-15 | 2020-11-17 | Bristol-Myers Squibb Company | compostos de éter de indol substituído |
| FI3728252T3 (fi) | 2017-12-18 | 2023-10-18 | Bristol Myers Squibb Co | 4-atsaindoliyhdisteitä |
| JP7313354B2 (ja) | 2017-12-19 | 2023-07-24 | ブリストル－マイヤーズ スクイブ カンパニー | Ｔｌｒ阻害剤として有用なアミド置換されたインドール化合物 |
| WO2019126082A1 (en) | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | 6-azaindole compounds |
| BR112020012084A2 (pt) | 2017-12-19 | 2020-11-24 | Bristol-Myers Squibb Company | compostos de indol substituído úteis como inibidores de tlr |
| US11299501B2 (en) | 2017-12-20 | 2022-04-12 | Bristol-Myers Squibb Company | Diazaindole compounds |
| BR112020011984A2 (pt) | 2017-12-20 | 2020-11-17 | Bristol-Myers Squibb Company | compostos de amino indol úteis como inibidores de tlr |
| CA3085942A1 (en) * | 2017-12-20 | 2019-06-27 | Bristol-Myers Squibb Company | Aryl and heteroaryl substituted indole compounds |
| WO2019136147A1 (en) * | 2018-01-03 | 2019-07-11 | The Board Of Trustees Of The University Of Illinois | Toll-like receptor signaling inhibitors |
| MX2021001565A (es) | 2018-08-08 | 2021-04-19 | Bristol Myers Squibb Co | Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad). |
-
2021
- 2021-08-18 AR ARP210102330A patent/AR123286A1/es not_active Application Discontinuation
- 2021-08-18 PE PE2023000281A patent/PE20230843A1/es unknown
- 2021-08-18 AU AU2021329323A patent/AU2021329323A1/en not_active Abandoned
- 2021-08-18 MX MX2023001884A patent/MX2023001884A/es unknown
- 2021-08-18 WO PCT/US2021/046421 patent/WO2022040260A1/en not_active Ceased
- 2021-08-18 US US18/041,719 patent/US12492188B2/en active Active
- 2021-08-18 TW TW110130430A patent/TW202227409A/zh unknown
- 2021-08-18 JP JP2023512228A patent/JP2023538619A/ja active Pending
- 2021-08-18 BR BR112023002645A patent/BR112023002645A2/pt not_active Application Discontinuation
- 2021-08-18 CA CA3189873A patent/CA3189873A1/en active Pending
- 2021-08-18 CN CN202180055586.XA patent/CN116075510A/zh active Pending
- 2021-08-18 EP EP21766787.2A patent/EP4200292B1/en active Active
- 2021-08-18 IL IL300702A patent/IL300702A/en unknown
- 2021-08-18 ES ES21766787T patent/ES2999539T3/es active Active
- 2021-08-18 KR KR1020237009017A patent/KR20230053645A/ko active Pending
-
2023
- 2023-02-13 CL CL2023000440A patent/CL2023000440A1/es unknown
- 2023-02-15 CO CONC2023/0001668A patent/CO2023001668A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538619A5 (enExample) | ||
| IL300702A (en) | 1H-BENZO[D]IMIDAZOLE derivatives as TLR9 inhibitors for the treatment of fibrosis | |
| HRP20231253T1 (hr) | Supstituirani spojevi naftiridina korisni kao aktivatori t stanica | |
| JP6339595B2 (ja) | 炎症性障害の治療のための化合物及びその医薬組成物 | |
| DK2096919T3 (en) | SUBSTITUTED 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINE DERIVATIVES USED FOR TREATING HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
| RU2016124178A (ru) | Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет | |
| JP2020527560A5 (enExample) | ||
| JP2017530960A5 (enExample) | ||
| RU2017105296A (ru) | Новые соединения | |
| JP2019529529A (ja) | 細胞代謝過程の阻害剤 | |
| JP2013520407A5 (enExample) | ||
| JP2014530238A5 (enExample) | ||
| US20190241533A1 (en) | Novel compounds and compositions for inhibition of fasn | |
| ME02330B (me) | Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspir0[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora | |
| AR072201A1 (es) | 2-arilaminoquinazolinas para el tratamiento de enfermedades proliferativas | |
| JP2019504821A5 (enExample) | ||
| RU2015129538A (ru) | Замещенные имидазопиридины в качестве ингибиторов hdm2 | |
| RU2012139830A (ru) | Производные пиразолопиперидина в качестве ингибиторов nadph - оксидазы | |
| JP2014511884A5 (enExample) | ||
| JP2016525072A (ja) | 炎症性障害の治療のための新規化合物及びその医薬組成物 | |
| JP2007520559A (ja) | 治療薬としてのアミノベンゾオキサゾール類 | |
| EP2594270A2 (en) | The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) | |
| JP7322052B2 (ja) | 新規アリールもしくはヘテロアリールトリアゾロン誘導体もしくはそれらの塩、またはそれを含む医薬組成物 | |
| JP2013515033A5 (enExample) | ||
| KR102788118B1 (ko) | 신규한 트리아졸론 유도체 또는 그의 염, 및 그를 포함하는 제약 조성물 |